CGA
Crescent Grove Advisors’s Gilead Sciences GILD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-5,836
| Closed | -$484K | – | 297 |
|
|
2023
Q1 | $484K | Sell |
5,836
-238
| -4% | -$19.7K | 0.06% | 172 |
|
|
2022
Q4 | $521K | Sell |
6,074
-3,836
| -39% | -$329K | 0.05% | 172 |
|
|
2022
Q3 | $611K | Buy |
+9,910
| New | +$611K | 0.07% | 143 |
|
|
2022
Q1 | – | Sell |
-4,180
| Closed | -$303K | – | 299 |
|
|
2021
Q4 | $303K | Buy |
+4,180
| New | +$303K | 0.03% | 232 |
|
|
2021
Q3 | – | Sell |
-4,237
| Closed | -$292K | – | 278 |
|
|
2021
Q2 | $292K | Buy |
+4,237
| New | +$292K | 0.03% | 199 |
|
|
2018
Q1 | – | Sell |
-3,014
| Closed | -$216K | – | 146 |
|
|
2017
Q4 | $216K | Hold |
3,014
| – | – | 0.05% | 126 |
|
|
2017
Q3 | $244K | Buy |
3,014
+14
| +0.5% | +$1.13K | 0.06% | 117 |
|
|
2017
Q2 | $212K | Buy |
+3,000
| New | +$212K | 0.06% | 130 |
|